 | • レポートコード：QAF27907 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の治療用酵素市場について種類別（注射剤、経口、局所）、用途別（ゴーシェ病、MPS病、胃腸疾患、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・治療用酵素市場の概要 ・世界の主要地域別治療用酵素市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の治療用酵素市場規模2016-2021：種類別（注射剤、経口、局所） ・世界の治療用酵素市場予測2012-2027：種類別（注射剤、経口、局所） ・世界の治療用酵素市場規模2016-2021：用途別（ゴーシェ病、MPS病、胃腸疾患、その他） ・世界の治療用酵素市場予測2012-2027：用途別（ゴーシェ病、MPS病、胃腸疾患、その他） ・治療用酵素のアメリカ市場規模と予測2016-2021 ・治療用酵素のヨーロッパ市場規模と予測2016-2021 ・治療用酵素の中国市場規模と予測2016-2021 ・治療用酵素の日本市場規模と予測2016-2021 ・治療用酵素の東南アジア市場規模と予測2016-2021 ・治療用酵素のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、BioMarin、AbbVie、Shire、Alexion、Horizon Pharma、Allergan、Johnson & Johnson、Recordati Rare Diseases、Pfizer、Vivus、Digestive Care、Leadiant Biosciences） ・治療用酵素の製造コスト分析 ・販売チャネル、流通業者、顧客 ・治療用酵素の市場動向・機会・課題 ・調査の結論 |
Therapeutic enzymes have a broad variety of specific uses, Oncolytics, Anticoagulants, Thrombolytics, Replacements for metabolic deficiencies, Digestive aids, Metabolic storage disorders, etc. Miscellaneous enzymes of diverse function.
Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% in 2018, followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.
Market Analysis and Insights: Global Therapeutic Enzymes Market
The global Therapeutic Enzymes market was valued at US$ 11400 in 2020 and will reach US$ 22620 million by the end of 2027, growing at a CAGR of 12.1% during 2022-2027.
Global Therapeutic Enzymes Scope and Market Size
The global Therapeutic Enzymes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injectable
Oral
Topical
Oral had the biggest market share of 94% in 2018.
Segment by Application
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
MPS Disease is the greatest segment of Therapeutic Enzymes application, with a share of 22% in 2018.
The Therapeutic Enzymes market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Enzymes market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Leadiant Biosciences
1 Therapeutic Enzymes Market Overview
1.1 Therapeutic Enzymes Product Scope
1.2 Therapeutic Enzymes Segment by Type
1.2.1 Global Therapeutic Enzymes Sales by Type (2016 & 2021 & 2027)
1.2.2 Injectable
1.2.3 Oral
1.2.4 Topical
1.3 Therapeutic Enzymes Segment by Application
1.3.1 Global Therapeutic Enzymes Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Gaucher Disease
1.3.3 MPS Disease
1.3.4 Gastrointestinal Diseases
1.3.5 Others
1.4 Therapeutic Enzymes Market Estimates and Forecasts (2016-2027)
1.4.1 Global Therapeutic Enzymes Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Therapeutic Enzymes Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Therapeutic Enzymes Price Trends (2016-2027)
2 Therapeutic Enzymes Estimates and Forecasts by Region
2.1 Global Therapeutic Enzymes Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Therapeutic Enzymes Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Therapeutic Enzymes Sales Market Share by Region (2016-2021)
2.2.2 Global Therapeutic Enzymes Revenue Market Share by Region (2016-2021)
2.3 Global Therapeutic Enzymes Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Therapeutic Enzymes Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Therapeutic Enzymes Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Therapeutic Enzymes Estimates and Projections (2016-2027)
2.4.2 Europe Therapeutic Enzymes Estimates and Projections (2016-2027)
2.4.3 China Therapeutic Enzymes Estimates and Projections (2016-2027)
2.4.4 Japan Therapeutic Enzymes Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Therapeutic Enzymes Estimates and Projections (2016-2027)
2.4.6 India Therapeutic Enzymes Estimates and Projections (2016-2027)
3 Global Therapeutic Enzymes Competition Landscape by Players
3.1 Global Top Therapeutic Enzymes Players by Sales (2016-2021)
3.2 Global Top Therapeutic Enzymes Players by Revenue (2016-2021)
3.3 Global Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Enzymes as of 2020)
3.4 Global Therapeutic Enzymes Average Price by Company (2016-2021)
3.5 Manufacturers Therapeutic Enzymes Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Therapeutic Enzymes Market Size by Type
4.1 Global Therapeutic Enzymes Historic Market Review by Type (2016-2021)
4.1.1 Global Therapeutic Enzymes Sales Market Share by Type (2016-2021)
4.1.2 Global Therapeutic Enzymes Revenue Market Share by Type (2016-2021)
4.1.3 Global Therapeutic Enzymes Price by Type (2016-2021)
4.2 Global Therapeutic Enzymes Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Therapeutic Enzymes Sales Forecast by Type (2022-2027)
4.2.2 Global Therapeutic Enzymes Revenue Forecast by Type (2022-2027)
4.2.3 Global Therapeutic Enzymes Price Forecast by Type (2022-2027)
5 Global Therapeutic Enzymes Market Size by Application
5.1 Global Therapeutic Enzymes Historic Market Review by Application (2016-2021)
5.1.1 Global Therapeutic Enzymes Sales Market Share by Application (2016-2021)
5.1.2 Global Therapeutic Enzymes Revenue Market Share by Application (2016-2021)
5.1.3 Global Therapeutic Enzymes Price by Application (2016-2021)
5.2 Global Therapeutic Enzymes Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Therapeutic Enzymes Sales Forecast by Application (2022-2027)
5.2.2 Global Therapeutic Enzymes Revenue Forecast by Application (2022-2027)
5.2.3 Global Therapeutic Enzymes Price Forecast by Application (2022-2027)
6 North America Therapeutic Enzymes Market Facts & Figures
6.1 North America Therapeutic Enzymes Sales by Company
6.1.1 North America Therapeutic Enzymes Sales by Company (2016-2021)
6.1.2 North America Therapeutic Enzymes Revenue by Company (2016-2021)
6.2 North America Therapeutic Enzymes Sales Breakdown by Type
6.2.1 North America Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
6.2.2 North America Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
6.3 North America Therapeutic Enzymes Sales Breakdown by Application
6.3.1 North America Therapeutic Enzymes Sales Breakdown by Application (2016-2021)
6.3.2 North America Therapeutic Enzymes Sales Breakdown by Application (2022-2027)
7 Europe Therapeutic Enzymes Market Facts & Figures
7.1 Europe Therapeutic Enzymes Sales by Company
7.1.1 Europe Therapeutic Enzymes Sales by Company (2016-2021)
7.1.2 Europe Therapeutic Enzymes Revenue by Company (2016-2021)
7.2 Europe Therapeutic Enzymes Sales Breakdown by Type
7.2.1 Europe Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
7.2.2 Europe Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
7.3 Europe Therapeutic Enzymes Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Therapeutic Enzymes Market Facts & Figures
8.1 China Therapeutic Enzymes Sales by Company
8.1.1 China Therapeutic Enzymes Sales by Company (2016-2021)
8.1.2 China Therapeutic Enzymes Revenue by Company (2016-2021)
8.2 China Therapeutic Enzymes Sales Breakdown by Type
8.2.1 China Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
8.2.2 China Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
8.3 China Therapeutic Enzymes Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Therapeutic Enzymes Market Facts & Figures
9.1 Japan Therapeutic Enzymes Sales by Company
9.1.1 Japan Therapeutic Enzymes Sales by Company (2016-2021)
9.1.2 Japan Therapeutic Enzymes Revenue by Company (2016-2021)
9.2 Japan Therapeutic Enzymes Sales Breakdown by Type
9.2.1 Japan Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
9.2.2 Japan Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
9.3 Japan Therapeutic Enzymes Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Therapeutic Enzymes Market Facts & Figures
10.1 Southeast Asia Therapeutic Enzymes Sales by Company
10.1.1 Southeast Asia Therapeutic Enzymes Sales by Company (2016-2021)
10.1.2 Southeast Asia Therapeutic Enzymes Revenue by Company (2016-2021)
10.2 Southeast Asia Therapeutic Enzymes Sales Breakdown by Type
10.2.1 Southeast Asia Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Therapeutic Enzymes Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Therapeutic Enzymes Market Facts & Figures
11.1 India Therapeutic Enzymes Sales by Company
11.1.1 India Therapeutic Enzymes Sales by Company (2016-2021)
11.1.2 India Therapeutic Enzymes Revenue by Company (2016-2021)
11.2 India Therapeutic Enzymes Sales Breakdown by Type
11.2.1 India Therapeutic Enzymes Sales Breakdown by Type (2016-2021)
11.2.2 India Therapeutic Enzymes Sales Breakdown by Type (2022-2027)
11.3 India Therapeutic Enzymes Sales Breakdown by Application
11.3.1 India Therapeutic Enzymes Sales Breakdown by Application (2016-2021)
11.3.2 India Therapeutic Enzymes Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Therapeutic Enzymes Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Therapeutic Enzymes Products Offered
12.1.5 Sanofi Recent Development
12.2 BioMarin
12.2.1 BioMarin Corporation Information
12.2.2 BioMarin Business Overview
12.2.3 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.2.4 BioMarin Therapeutic Enzymes Products Offered
12.2.5 BioMarin Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Business Overview
12.3.3 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AbbVie Therapeutic Enzymes Products Offered
12.3.5 AbbVie Recent Development
12.4 Shire
12.4.1 Shire Corporation Information
12.4.2 Shire Business Overview
12.4.3 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Shire Therapeutic Enzymes Products Offered
12.4.5 Shire Recent Development
12.5 Alexion
12.5.1 Alexion Corporation Information
12.5.2 Alexion Business Overview
12.5.3 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Alexion Therapeutic Enzymes Products Offered
12.5.5 Alexion Recent Development
12.6 Horizon Pharma
12.6.1 Horizon Pharma Corporation Information
12.6.2 Horizon Pharma Business Overview
12.6.3 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Horizon Pharma Therapeutic Enzymes Products Offered
12.6.5 Horizon Pharma Recent Development
12.7 Allergan
12.7.1 Allergan Corporation Information
12.7.2 Allergan Business Overview
12.7.3 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Allergan Therapeutic Enzymes Products Offered
12.7.5 Allergan Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Corporation Information
12.8.2 Johnson & Johnson Business Overview
12.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johnson & Johnson Therapeutic Enzymes Products Offered
12.8.5 Johnson & Johnson Recent Development
12.9 Recordati Rare Diseases
12.9.1 Recordati Rare Diseases Corporation Information
12.9.2 Recordati Rare Diseases Business Overview
12.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Recordati Rare Diseases Therapeutic Enzymes Products Offered
12.9.5 Recordati Rare Diseases Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Business Overview
12.10.3 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Therapeutic Enzymes Products Offered
12.10.5 Pfizer Recent Development
12.11 Vivus
12.11.1 Vivus Corporation Information
12.11.2 Vivus Business Overview
12.11.3 Vivus Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Vivus Therapeutic Enzymes Products Offered
12.11.5 Vivus Recent Development
12.12 Digestive Care
12.12.1 Digestive Care Corporation Information
12.12.2 Digestive Care Business Overview
12.12.3 Digestive Care Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Digestive Care Therapeutic Enzymes Products Offered
12.12.5 Digestive Care Recent Development
12.13 Leadiant Biosciences
12.13.1 Leadiant Biosciences Corporation Information
12.13.2 Leadiant Biosciences Business Overview
12.13.3 Leadiant Biosciences Therapeutic Enzymes Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Leadiant Biosciences Therapeutic Enzymes Products Offered
12.13.5 Leadiant Biosciences Recent Development
13 Therapeutic Enzymes Manufacturing Cost Analysis
13.1 Therapeutic Enzymes Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Therapeutic Enzymes
13.4 Therapeutic Enzymes Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Therapeutic Enzymes Distributors List
14.3 Therapeutic Enzymes Customers
15 Market Dynamics
15.1 Therapeutic Enzymes Market Trends
15.2 Therapeutic Enzymes Drivers
15.3 Therapeutic Enzymes Market Challenges
15.4 Therapeutic Enzymes Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Therapeutic Enzymes Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Therapeutic Enzymes Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Therapeutic Enzymes Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Therapeutic Enzymes Sales (K Units) by Region (2016-2021)
Table 5. Global Therapeutic Enzymes Sales Market Share by Region (2016-2021)
Table 6. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Therapeutic Enzymes Revenue Share by Region (2016-2021)
Table 8. Global Therapeutic Enzymes Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Therapeutic Enzymes Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Therapeutic Enzymes Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Therapeutic Enzymes Revenue Share Forecast by Region (2022-2027)
Table 12. Global Therapeutic Enzymes Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Therapeutic Enzymes Sales Share by Company (2016-2021)
Table 14. Global Therapeutic Enzymes Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Therapeutic Enzymes Revenue Share by Company (2016-2021)
Table 16. Global Therapeutic Enzymes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Enzymes as of 2020)
Table 17. Global Therapeutic Enzymes Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Therapeutic Enzymes Manufacturing Sites and Area Served
Table 19. Manufacturers Therapeutic Enzymes Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Therapeutic Enzymes Sales (K Units) by Type (2016-2021)
Table 22. Global Therapeutic Enzymes Sales Share by Type (2016-2021)
Table 23. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Therapeutic Enzymes Price (USD/Unit) by Type (2016-2021)
Table 25. Global Therapeutic Enzymes Sales Share by Type (2022-2027)
Table 26. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Therapeutic Enzymes Revenue Share by Type (2022-2027)
Table 28. Global Therapeutic Enzymes Price (USD/Unit) by Type (2022-2027)
Table 29. Global Therapeutic Enzymes Sales (K Units) by Application (2016-2021)
Table 30. Global Therapeutic Enzymes Sales Share by Application (2016-2021)
Table 31. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Therapeutic Enzymes Price (USD/Unit) by Application (2016-2021)
Table 33. Global Therapeutic Enzymes Sales (K Units) by Application (2022-2027)
Table 34. Global Therapeutic Enzymes Sales Share by Application (2022-2027)
Table 35. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Therapeutic Enzymes Revenue Share by Application (2022-2027)
Table 37. Global Therapeutic Enzymes Price (USD/Unit) by Application (2022-2027)
Table 38. North America Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 39. North America Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 40. North America Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 42. North America Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 43. North America Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 44. North America Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 45. North America Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 46. North America Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 47. North America Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 48. North America Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 49. North America Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 50. Europe Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 51. Europe Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 52. Europe Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 54. Europe Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 55. Europe Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 56. Europe Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 57. Europe Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 58. Europe Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 59. Europe Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 60. Europe Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 61. Europe Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 62. China Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 63. China Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 64. China Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 66. China Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 67. China Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 68. China Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 69. China Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 70. China Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 71. China Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 72. China Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 73. China Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 74. Japan Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 75. Japan Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 76. Japan Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 78. Japan Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 79. Japan Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 80. Japan Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 81. Japan Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 82. Japan Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 83. Japan Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 84. Japan Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 85. Japan Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 98. India Therapeutic Enzymes Sales (K Units) by Company (2016-2021)
Table 99. India Therapeutic Enzymes Sales Market Share by Company (2016-2021)
Table 100. India Therapeutic Enzymes Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Therapeutic Enzymes Revenue Market Share by Company (2016-2021)
Table 102. India Therapeutic Enzymes Sales by Type (2016-2021) & (K Units)
Table 103. India Therapeutic Enzymes Sales Market Share by Type (2016-2021)
Table 104. India Therapeutic Enzymes Sales by Type (2022-2027) & (K Units)
Table 105. India Therapeutic Enzymes Sales Market Share by Type (2022-2027)
Table 106. India Therapeutic Enzymes Sales by Application (2016-2021) & (K Units)
Table 107. India Therapeutic Enzymes Sales Market Share by Application (2016-2021)
Table 108. India Therapeutic Enzymes Sales by Application (2022-2027) & (K Units)
Table 109. India Therapeutic Enzymes Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Sanofi Therapeutic Enzymes Product
Table 114. Sanofi Recent Development
Table 115. BioMarin Corporation Information
Table 116. BioMarin Description and Business Overview
Table 117. BioMarin Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. BioMarin Therapeutic Enzymes Product
Table 119. BioMarin Recent Development
Table 120. AbbVie Corporation Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. AbbVie Therapeutic Enzymes Product
Table 124. AbbVie Recent Development
Table 125. Shire Corporation Information
Table 126. Shire Description and Business Overview
Table 127. Shire Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Shire Therapeutic Enzymes Product
Table 129. Shire Recent Development
Table 130. Alexion Corporation Information
Table 131. Alexion Description and Business Overview
Table 132. Alexion Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Alexion Therapeutic Enzymes Product
Table 134. Alexion Recent Development
Table 135. Horizon Pharma Corporation Information
Table 136. Horizon Pharma Description and Business Overview
Table 137. Horizon Pharma Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Horizon Pharma Therapeutic Enzymes Product
Table 139. Horizon Pharma Recent Development
Table 140. Allergan Corporation Information
Table 141. Allergan Description and Business Overview
Table 142. Allergan Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Allergan Therapeutic Enzymes Product
Table 144. Allergan Recent Development
Table 145. Johnson & Johnson Corporation Information
Table 146. Johnson & Johnson Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Johnson & Johnson Description and Business Overview
Table 148. Johnson & Johnson Therapeutic Enzymes Product
Table 149. Johnson & Johnson Recent Development
Table 150. Recordati Rare Diseases Corporation Information
Table 151. Recordati Rare Diseases Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Recordati Rare Diseases Description and Business Overview
Table 153. Recordati Rare Diseases Therapeutic Enzymes Product
Table 154. Recordati Rare Diseases Recent Development
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Business Overview
Table 157. Pfizer Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Pfizer Therapeutic Enzymes Product
Table 159. Pfizer Recent Development
Table 160. Vivus Corporation Information
Table 161. Vivus Description and Business Overview
Table 162. Vivus Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Vivus Therapeutic Enzymes Product
Table 164. Vivus Recent Development
Table 165. Digestive Care Corporation Information
Table 166. Digestive Care Description and Business Overview
Table 167. Digestive Care Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Digestive Care Therapeutic Enzymes Product
Table 169. Digestive Care Recent Development
Table 170. Leadiant Biosciences Corporation Information
Table 171. Leadiant Biosciences Description and Business Overview
Table 172. Leadiant Biosciences Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Leadiant Biosciences Therapeutic Enzymes Product
Table 174. Leadiant Biosciences Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Therapeutic Enzymes Distributors List
Table 178. Therapeutic Enzymes Customers List
Table 179. Therapeutic Enzymes Market Trends
Table 180. Therapeutic Enzymes Market Drivers
Table 181. Therapeutic Enzymes Market Challenges
Table 182. Therapeutic Enzymes Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Enzymes Product Picture
Figure 2. Global Therapeutic Enzymes Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Therapeutic Enzymes Sales Market Share by Application in 2021 & 2027
Figure 6. Gaucher Disease Examples
Figure 7. MPS Disease Examples
Figure 8. Gastrointestinal Diseases Examples
Figure 9. Others Examples
Figure 10. Global Therapeutic Enzymes Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Therapeutic Enzymes Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Therapeutic Enzymes Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Therapeutic Enzymes Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Therapeutic Enzymes Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Therapeutic Enzymes Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Therapeutic Enzymes Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Therapeutic Enzymes Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Therapeutic Enzymes Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Therapeutic Enzymes Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Therapeutic Enzymes Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Therapeutic Enzymes Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Therapeutic Enzymes Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Therapeutic Enzymes Players Market Share by Revenue in Therapeutic Enzymes: 2016 & 2020
Figure 29. Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Therapeutic Enzymes Revenue Share by Type (2016-2021)
Figure 31. Global Therapeutic Enzymes Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Therapeutic Enzymes Revenue Share by Application (2016-2021)
Figure 33. Global Therapeutic Enzymes Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 35. North America Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 36. Europe Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 37. Europe Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 38. China Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 39. China Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 40. Japan Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 41. Japan Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 42. Southeast Asia Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 43. Southeast Asia Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 44. India Therapeutic Enzymes Sales Market Share by Type in 2020
Figure 45. India Therapeutic Enzymes Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Therapeutic Enzymes
Figure 48. Manufacturing Process Analysis of Therapeutic Enzymes
Figure 49. Therapeutic Enzymes Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の寄生虫病治療市場規模・現状・予測（2021年-2027年） Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria. Market Analysis and Insights: Global Parasitic Diseases Therapeutic Market The global Parasitic Diseases Therapeutic market size is projected to reach US$ XX mill…- 工業用酵素のグローバル市場2021 Enzymes are protein molecules functioning as specialized catalysts for chemical reactions. They have contributed greatly to the traditional and modern chemical industry by improving existing processes. Technical enzymes are typically used as bulk enzymes in textile, pulp and paper industries, organi…
- 医療用酵素のグローバル市場2021 Medical Specialty Enzymes contains the enzymes used for pharmaceutical and diagnostic applications. Amano Enzymes was the global greatest company in Medical Specialty Enzymes industry, with the revenue market Share of 13% in 2018, followed by Sekisui, Novozymes, Roche CustomBiotech, BBI Solutions, A…
- 世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…